274 related articles for article (PubMed ID: 32279585)
1. CD4
Kosmaczewska A; Ciszak L; Stosio M; Szteblich A; Madej M; Frydecka I; Wiland P; Szmyrka M
Lupus; 2020 Jun; 29(7):705-714. PubMed ID: 32279585
[TBL] [Abstract][Full Text] [Related]
2. Preserved specific anti-viral T-cell response but associated with decreased lupus activity in SLE patients with cytomegalovirus infection.
Wu CS; Chyuan IT; Chiu YL; Chen WL; Shen CY; Hsu PN
Rheumatology (Oxford); 2020 Nov; 59(11):3340-3349. PubMed ID: 32306043
[TBL] [Abstract][Full Text] [Related]
3. Imbalance between CD8
Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
[TBL] [Abstract][Full Text] [Related]
4. Immunological role of CD4
ElAlfy MS; Adly AAM; Ebeid FSE; Eissa DS; Ismail EAR; Mohammed YH; Ahmed ME; Saad AS
Immunol Res; 2018 Aug; 66(4):480-490. PubMed ID: 29926339
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
[TBL] [Abstract][Full Text] [Related]
6. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B.
Harigai M; Kawamoto M; Hara M; Kubota T; Kamatani N; Miyasaka N
J Immunol; 2008 Aug; 181(3):2211-9. PubMed ID: 18641361
[TBL] [Abstract][Full Text] [Related]
7. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes.
Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P
Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616
[TBL] [Abstract][Full Text] [Related]
8. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
9. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical changes and clinical significance of CD4
Yuan S; Zeng Y; Li J; Wang C; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Yu N; Cai X
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35732344
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
13. Senescent profile of angiogenic T cells from systemic lupus erythematosus patients.
López P; Rodríguez-Carrio J; Martínez-Zapico A; Caminal-Montero L; Suarez A
J Leukoc Biol; 2016 Mar; 99(3):405-12. PubMed ID: 26232454
[TBL] [Abstract][Full Text] [Related]
14. Association of Graves' disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells.
Sun Z; Zhong W; Lu X; Shi B; Zhu Y; Chen L; Zhang G; Zhang X
J Clin Immunol; 2008 Sep; 28(5):464-72. PubMed ID: 18704663
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.
Shah K; Lee WW; Lee SH; Kim SH; Kang SW; Craft J; Kang I
Arthritis Res Ther; 2010; 12(2):R53. PubMed ID: 20334681
[TBL] [Abstract][Full Text] [Related]
16. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
18. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of circulating CD4+CD28null T cells is associated with early atherosclerotic damage in patients with end-stage renal disease undergoing hemodialysis.
Sun Z; Ye H; Tang B; Shen X; Wu X; Zhong H; Song W
Hum Immunol; 2013 Jan; 74(1):6-13. PubMed ID: 22902395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]